Aims And Objectives: To determine the effectiveness of an electronic messaging support service for management of cardiovascular risk factors in patients with diabetes.
Background: Microletter and short message service are widely used, but their health education benefit for people with type 2 diabetes mellitus has not been investigated.
Design: Convenience sample study with randomised group assignment.
Methods: Participants completed survey questionnaires, physical and laboratory evaluations between May 2015 and May 2016 and were then randomly assigned to two groups for receipt of a microletter + short message or a phone call (control). Appointment reminders and health information were sent to the intervention patients by microletter + short message. Every three months, intervention patients and control patients were followed up by telephone. After 12 months, changes in cardiovascular risk factors in each group were evaluated and compared.
Results: There were no statistically significant changes or between-group differences in daily smoking and drinking. There were statistically significant between-group differences in glycated haemoglobin (p = .034), postprandial plasma glucose (p = .001), postprandial insulin (p = .005), total cholesterol (p = .038) and low-density lipoprotein (p < .001). Levels of glycated haemoglobin (p = .011), fasting plasma glucose (p = .007), postprandial plasma glucose (p < .001), fasting insulin (p = 0.004), postprandial insulin (p < .001), total cholesterol (p < .001) and low-density lipoprotein (p < .001) were found to be decreased significantly in intervention patients. Systolic blood pressure decreased significantly in patients only followed by telephone (p = .014). The microletter + short message intervention was an effective means of reducing cardiovascular risk in patients with type 2 diabetes mellitus.
Conclusion: Regular smartphone communication had a favourable impact on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Relevance To Clinical Practice: Regular smartphone communication has a favourable impact on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jocn.13962 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Circadian Misalignment Impacts Cardiac Autonomic Modulation in Adolescence.
Sleep
January 2025
Sleep Research & Treatment Center, Department of Psychiatry & Behavioral Health, Penn State University, College of Medicine, Hershey PA, USA.
Study Objectives: Although heart rate variability (HRV), a marker of cardiac autonomic modulation (CAM), is known to predict cardiovascular morbidity, the circadian timing of sleep (CTS) is also involved in autonomic modulation. We examined whether circadian misalignment is associated with blunted HRV in adolescents as a function of entrainment to school or on-breaks.
Methods: We evaluated 360 subjects from the Penn State Child Cohort (median 16y) who had at least 3-night at-home actigraphy (ACT), in-lab 9-h polysomnography (PSG) and 24-h Holter-monitoring heart rate variability (HRV) data.
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
Dig Dis Sci
January 2025
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan, 70401, Taiwan.
Aim: Sarcopenic obesity (SO) is associated with adverse outcomes in diseased patients. This study aimed to examine the prevalence and risks associated with SO, with a focus on the impact of SO on cardiovascular risk in patients with MASLD.
Materials And Methods: In this cross-sectional study, patients with MASLD were prospectively enrolled.
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults.
Drugs Aging
January 2025
Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, 420 East 70th St, New York, NY, LH-36510063, USA.
There are several pharmacologic agents that have been touted as guideline-directed medical therapy for heart failure with preserved ejection fraction (HFpEF). However, it is important to recognize that older adults with HFpEF also contend with an increased risk for adverse effects from medications due to age-related changes in pharmacokinetics and pharmacodynamics of medications, as well as the concurrence of geriatric conditions such as polypharmacy and frailty. With this review, we discuss the underlying evidence for the benefits of various treatments in HFpEF and incorporate key considerations for older adults, a subpopulation that may be at higher risk for adverse drug events.
View Article and Find Full Text PDFCardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.
Curr Cardiol Rep
January 2025
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Purpose Of Review: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, characterized by hepatic steatosis with at least one cardiometabolic risk factor. Patients with MASLD are at increased risk for the occurrence of cardiovascular events. Within this review article, we aimed to provide an update on the pathophysiology of MASLD, its interplay with cardiovascular disease, and current treatment strategies.
View Article and Find Full Text PDFUnraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.
Cardiovasc Toxicol
January 2025
RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
The rapid development and deployment of mRNA and non-mRNA COVID-19 vaccines have played a pivotal role in mitigating the global pandemic. Despite their success in reducing severe disease outcomes, emerging concerns about cardiovascular complications have raised questions regarding their safety. This systematic review critically evaluates the evidence on the cardiovascular effects of COVID-19 vaccines, assessing both their protective and adverse impacts, while considering the challenges posed by the limited availability of randomized controlled trial (RCT) data on these rare adverse events.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!